Joshua Sabari, MD, is a thoracic medical oncologist and Assistant Professor of Medicine specializing in the care of patients with thoracic malignancies. He serves at NYU Langone Health’s Perlmutter Cancer Center as Medical Director of Thoracic Medical Oncology and Medical Director of High Reliability Organization Initiatives, and is a key member of the Phase I Experimental Therapeutics Group within the Department of Medical Oncology. Clinically, Dr. Sabari focuses on precision oncology for thoracic cancers, integrating molecular and biomarker testing into treatment planning, advancing access to early-phase clinical trials, and partnering closely with patients through education and advocacy. His research interests include targeted therapy development, translational approaches that connect tumor biology to therapeutic strategy, and understanding and overcoming treatment resistance to improve outcomes. Dr. Sabari’s leadership also extends to medical communication and survivorship education as Editor-in-Chief of CURE Magazine. He has been recognized as a Distinguished Young Investigator (Honorable Mention) at the EGFR Resisters Research Summit and is a frequent invited speaker at major international oncology meetings. He earned his MD from The George Washington University School of Medicine and Health Sciences, completed an Internal Medicine residency at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and completed a Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center.
Assistant Professor
Medical School
2007 – 2011
Residency
2011 – 2015
Fellowship
2015 – 2018